Pathogenic role of Acinetobacter spp. during HIV infection;Ruolo patogeno di Acinetobacter spp. in corso di infezione da HIV

Infezioni in Medicina

Volumn 9, Issue 1, 2001, Pages 43-51

  Manfredi, R ^a   Nanetti, A ^a   Valentini, R ^a   Chiodo, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; NETILMICIN; PIPERACILLIN; QUINOLINE DERIVATIVE;

ACINETOBACTER CALCOACETICUS; ACINETOBACTER LWOFFII; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CORTICOSTEROID THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUTROPENIA; PATHOGENESIS; SEPSIS; SUPERINFECTION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE; FEMALE; HIV INFECTIONS; HUMANS; ITALY; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS;

EID: 0035075058     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals
2. HIV-associated non-mycobacterial sepsis-bacteremia, before and during the highly active antiretroviral therapy era
3. Xanthomonas maltophilia: An emerging pathogen in patients with HIV disease
4. Nosocomial blood stream infections in HIV-infected patients: Attributable mortality and extension of hospital stay
5. Neutropenia is a risk factor for gramnegative bacillus bacteremia in human immunodeficiency virus-infected patients: Results of a nested case-control study
6. Bacterial pneumonia in HIV-infected patients
7. Pyogenic bacterial pneumonia in human immunodeficiency-virus infected inpatients: A clinical, radiological, microbiological, and epidemiological study
8. Bacterial infections in HIV: The extent and nature of the problem
9. Management of the HIV-infected patient. Bacterial infections
10. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens
11. Community-acquired bacteremia in HIV-positive patients: Protective benefit of co-trimoxazole
12. Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine
13. Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus
14. Nosocomial infections in human immunodeficiency virusinfected patients in a long-term care setting
15. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: A case-control study of risk factors and outcome
16. The impact of bacteremia on HIV infection. Nine years experience in a large Italian university hospital
17. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS
18. Central venous line infections in AIDS
19. Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus
20. Bacteremia in HIV-positive and AIDS patients: Incidence, species distribution, risk factors, outcome, and influence of long-term prophylactic antibiotic treatment
21. Editorial response: Changing epidemiology of nosocomial infections in human immunodeficiency virus-infected patients
22. Acinetobacter species: Which do we mean?
23. Acinetobacter spp. as nosocomial pathogens: Microbiologic, clinical, and epidemiological features
24. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality
25. Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings, and prognostic features
26. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology
27. Nosocomial outbreak of multi-resistant Acinetobacter baumannii in a surgical ward: Epidemiology and risk factors for acquisition
28. Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland
29. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients
30. Acinetobacter species as nosocomial pathogens
31. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners
32. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients
33. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii
34. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: A case-control study of adult burn patients
35. Bacteremia with Acinetobacter species: Risk factors and prognosis in different clinical settings
36. Nosocomial acquisition of multiresistant Acinetobacter baumannii: Risk factors and prognosis
37. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii
38. Leprosy in HIV-positive and syphilitic young Paraguayan man
39. Community-acquired pneumonia due to Acinetobacter lwoffii in a patient infected with the human immumodeficiency virus
40. Acinetobacter baumannii community-acquired pneumonia in a patient with HIV infection
41. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter spp. (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)
42. Antimicrobial susceptibility of Acinetobacter species
43. Effects of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus
44. Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network
45. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period
46. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
47. Urologic manifestations of AIDS
48. Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome
49. Bacterial infections in human immunodeficiency virus type-1 infected children: The impact of central venous catheters and antiretroviral agents
50. High HIV seroprevalency and increased HIV-associated mortality among hospitalized patients with deep bacterial infections in Dar es Salaam, Tanzania
51. Complications infectieuses des cathéters à chambre implantable chez des malades infectés par le VIH
52. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii